Calcitriol Modulates the CD46 Pathway in T Cells
Open Access
- 29 October 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (10) , e48486
Abstract
The complement regulator CD46 is a costimulatory molecule for human T cells that induces a regulatory Tr1 phenotype, characterized by large amounts of IL-10 secretion. Secretion of IL-10 upon CD46 costimulation is largely impaired in T cells from patients with multiple sclerosis (MS). Vitamin D can exert a direct effect on T cells, and may be beneficial in several pathologies, including MS. In this pilot study, we examined whether active vitamin D (1,25(OH)2D3 or calcitriol) could modulate the CD46 pathway and restore IL-10 production by CD46-costimulated CD4+ T cells from patients with MS. In healthy T cells, calcitriol profoundly affects the phenotype of CD46-costimulated CD4+ T cells, by increasing the expression of CD28, CD25, CTLA-4 and Foxp3 while it concomitantly decreased CD46 expression. Similar trends were observed in MS CD4+ T cells except for CD25 for which a striking opposite effect was observed: while CD25 was normally induced on MS T cells by CD46 costimulation, addition of calcitriol consistently inhibited its induction. Despite the aberrant effect on CD25 expression, calcitriol increased the IL-10:IFNγ ratio, characteristic of the CD46-induced Tr1 phenotype, in both T cells from healthy donors and patients with MS. Hence, we show that calcitriol affects the CD46 pathway, and that it promotes anti-inflammatory responses mediated by CD46. Moreover, it might be beneficial for T cell responses in MS.Keywords
This publication has 56 references indexed in Scilit:
- 1,25-Dihydroxyvitamin D3 inhibits proliferation but not the suppressive function of regulatory T cells in the absence of antigen-presenting cellsImmunology, 2011
- The Dynamic Processing of CD46 Intracellular Domains Provides a Molecular Rheostat for T Cell ActivationPLOS ONE, 2011
- Safety and T Cell Modulating Effects of High Dose Vitamin D3 Supplementation in Multiple SclerosisPLOS ONE, 2010
- 1,25-Dihydroxyvitamin D3 Inhibits the Differentiation and Migration of TH17 Cells to Protect against Experimental Autoimmune EncephalomyelitisPLOS ONE, 2010
- A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosisNeurology, 2010
- 1α,25‐dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infectionImmunology, 2009
- Ligation of TLR9 induced on human IL-10–secreting Tregs by 1α,25-dihydroxyvitamin D3 abrogates regulatory functionJournal of Clinical Investigation, 2009
- Ligation of the cell surface receptor, CD46, alters T cell polarity and response to antigen presentationProceedings of the National Academy of Sciences, 2006
- Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosisJournal of Clinical Investigation, 2006
- Levels of expression of complement regulatory proteins CD46, CD55 and CD59 on resting and activated human peripheral blood leucocytesImmunology, 2006